World Health Organization (WHO) has recognised the quality of products manufactured at Renata's Rajendrapur Potent Product Facility to be of an international standard, enabling the pharmaceutical to sell birth control pills abroad.
This will permit bidding on tenders in most countries, Renata said in a disclosure posted on the Dhaka Stock Exchange website today.
For all latest news, follow The Daily Star's Google News channel.
"This has opened a new horizon for the company. The contraceptive pill market is especially big in African countries and so we aim to grab it," said Zaki Chowdhury, general manager of international regulatory affairs at Renata.
The facility's yearly production capacity is 200 million packs.
Renata sells a big volume of its pills to the government. Besides, around 100 million packs are sold in the local markets every year.
Renata was incorporated in Bangladesh in 1972 as Pfizer Laboratories (Bangladesh) under the Companies Act 1913. The company was listed with Dhaka Stock Exchange on May 12, 1979.
Subsequently, the company was renamed Renata Limited in 1993. Its total sales stood at Tk 3,107 crore in the financial year of 2021-22.
Stocks of Renata, a leading blue-chip company, were traded at Tk 1,217 today.
